Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
10. Oktober 2024 12:30 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
Nucleic Acid Therapeutics CDMO Market Research Report 2024-2034 Featuring Strategic Analysis of Lonza Group, Catalent, and Thermo Fisher Scientific Among Others
28. Juni 2024 10:23 ET
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Nucleic Acid Therapeutics CDMO Market" report has been added to ResearchAndMarkets.com's offering.The global nucleic acid therapeutics CDMO...
Europe Nucleic Acid Therapeutics CDMO Market Analysis and Forecasts, 2023-2033: Increasing FDA or European Medicines Agency Approvals, Pharmaceutical Firms Becoming More Outsourcing-Oriented
28. Februar 2024 09:01 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Europe Nucleic Acid Therapeutics CDMO Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe...
Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Market to Reach $4.04 Billion by 2033 - Significant Number of Collaborations among Market Players
06. Dezember 2023 04:58 ET
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Nucleic Acid Therapeutics CDMO Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...